In this thrilling new battle game, players must uncover a hidden traitor among them. Will the disciples of light succeed in their quest, or will the disciple of shadow outsmart them all?
The Trump administration's recent claims linking acetaminophen use during pregnancy to autism risks have ignited outrage among autism advocates, who argue it perpetuates stigma and guilt for parents. Colin Killick, executive director of the Autistic Self Advocacy Network, voices concerns over the implications of these statements.
A new app, Neon Mobile, is climbing the charts by offering users money in exchange for recording their phone calls. While it promises substantial earnings, the implications for privacy and data security are alarming.
Qualcomm has launched the Snapdragon 8 Elite Gen 5, claiming it to be the fastest mobile chip ever. With significant performance boosts and advanced AI capabilities, it's set to revolutionize flagship smartphones from top brands.
As colder months bring respiratory illnesses, a new advisory recommends that you consult a pharmacist before getting your COVID vaccine. No prescription needed, but be prepared for a brief discussion.
The White House has issued a memo warning federal agencies to prepare for mass firings if Congress cannot avert a government shutdown. Tensions rise as Trump cancels meetings with Democrats over budget negotiations.
A shooting at an ICE facility in Dallas left one detainee dead and two critically injured. Acting Director Todd Lyons announced heightened security measures as officials investigate the potential political motives behind the attack.
In a race against time, Bear River Health officials moved swiftly to protect 11 exposed infants from measles, coordinating a vital response that involved notifying families and administering urgent treatments.
Jimmy Kimmel made a triumphant return to late-night TV, roasting Donald Trump as an '80s movie bully' and defending free speech amid controversy. His monologue drew record ratings, but criticisms linger.
Scientists from University College London have made a groundbreaking discovery that could slow the progression of Huntington’s disease. A new gene therapy, AMT-130, shows promising results in clinical trials, potentially changing lives forever.
